Accenture Plc (NYSE:ACN) shares came under pressure in early trading on Friday, even after the company reported upbeat results for its fiscal fourth quarter.

The company reported its results amid an exciting earnings season. Here are some key analyst takeaways.

Piper Sandler On Accenture

Analyst Arvind Ramnani upgraded the rating from Neutral to Overweight while lifting the price target from $329 to $395.

Accenture reported $1 billion in GenAI-related bookings, bringing the total GenAI bookings to $3 billion for fiscal 2024, of which $900 million were converted into revenues during the year, Ramnani said in the upgrade note.

Both bookings and revenues from GenAI grew by 10x in the year, he added.

The analyst stated he was bullish on “the underlying metrics,” which includes conservative guidance, robust bookings of $20.2 billion and a significant increase in hiring.

“Overall, we believe owning ACN is attractive, given improving top-line metrics, a conservative …

Full story available on Benzinga.com